{"version": "https://jsonfeed.org/version/1.1", "title": "Sharemaestro Newsreel: Australia Biotechnology news", "home_page_url": "https://sharemaestro.com/newsreel/au/healthcare/biotechnology/", "feed_url": "https://sharemaestro.com/newsreel/au/healthcare/biotechnology/feed.json", "description": "Latest Biotechnology company headlines from Australia, newest first, with source links and direct routes to company research and sentiment.", "language": "en", "items": [{"id": "source:4c7f957907b49a105197c1b54772608645bd032d34222ea31e0fc93ff3627b1b", "url": "https://news.google.com/rss/articles/CBMickFVX3lxTE11c2RpdVZzQ0wteUltWTlBQUh1Zms5ZTgtY1JhQ3BhWTZrQlFBVnZsZFViTlF5eHJMbVQtQmJhY1A4MUx6ZGZqQ01MaGNKUVFJTXBSTkRWbUlmN184TTdxd0F2RWowV3dlY0lFazFPZndvQQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMickFVX3lxTE11c2RpdVZzQ0wteUltWTlBQUh1Zms5ZTgtY1JhQ3BhWTZrQlFBVnZsZFViTlF5eHJMbVQtQmJhY1A4MUx6ZGZqQ01MaGNKUVFJTXBSTkRWbUlmN184TTdxd0F2RWowV3dlY0lFazFPZndvQQ?oc=5", "title": "Island Pharmaceuticals Ltd Revenue Breakdown \u2013 ASX:ILA", "content_text": "Island Pharmaceuticals Ltd Revenue Breakdown \u2013 ASX:ILA", "date_published": "2026-08-14T09:14:55+00:00", "authors": [{"name": "TradingView"}], "tags": ["Earnings", "ILA"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ILA", "name": "Island Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/183d4f14-bb74-4dca-92e1-9b0dc5ce2015/"}]}}, {"id": "source:742e49611d719d52b3e78dd19be949d1c91c0a8449a88b61053ca2f792818aec", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNUjdiQ1dqcWVoYy1tRk5VTzNQcW9fQkpkVkpLSkRSZktUOE54Q1JLM0JMXzhvMVdCWTlMRExTREhjdFlFVWpTZThaZjNlYmpFYU1rMkd0bGM4SnpMaGl6VlRGQlFUQ0g5UndBRXlmbmc5c1lleVViNmpjUnB0cGNjTmpTUGVKaXpoNGFkOVJkbHlMbmo1LXYtVW5OT2NKRDVVR3FnQVZJVWE3UFJCZk1qdWxaXzlDYXNXcXh0Uw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxNUjdiQ1dqcWVoYy1tRk5VTzNQcW9fQkpkVkpLSkRSZktUOE54Q1JLM0JMXzhvMVdCWTlMRExTREhjdFlFVWpTZThaZjNlYmpFYU1rMkd0bGM4SnpMaGl6VlRGQlFUQ0g5UndBRXlmbmc5c1lleVViNmpjUnB0cGNjTmpTUGVKaXpoNGFkOVJkbHlMbmo1LXYtVW5OT2NKRDVVR3FnQVZJVWE3UFJCZk1qdWxaXzlDYXNXcXh0Uw?oc=5", "title": "Amplia Therapeutics (ASX:ATX) Expands Narmafotinib Program Through Lung Cancer Trial", "content_text": "Amplia Therapeutics (ASX:ATX) Expands Narmafotinib Program Through Lung Cancer Trial", "date_published": "2026-08-14T06:30:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATX", "name": "Amplia Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/092cfe2d-9146-46c4-8b42-f095a50ab572/"}]}}, {"id": "source:6a5c42b2ab2d69c17229193487b4b644d80970133883b17aed586647d0579a71", "url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQT0QtWDJIS2FYOE1JZWg2WHFsTXpLcnM4d1FLaVJ1R0hCMnQyTUpqX2h6OVY3NnMtQUpWR3FZWlo3aExlU3l1WlVieHZrSzBoclg3YkpDQVM0TlZzaGZRRHhCVDJQakNvZ3hDS2xQUEExQXVyeXBtdDJwX3dWalN0YWpiZHpZVURDMlF4YVJSQWhHc0lZWEp2V0ZINkY2SWlRSnBpcWllU3dEeG5lVWZVM055T1VYSFphejVhdV84NFlIVWM1dnJOR3BLRjRlVTVldkYtTDYxTHo1QQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi2gFBVV95cUxQT0QtWDJIS2FYOE1JZWg2WHFsTXpLcnM4d1FLaVJ1R0hCMnQyTUpqX2h6OVY3NnMtQUpWR3FZWlo3aExlU3l1WlVieHZrSzBoclg3YkpDQVM0TlZzaGZRRHhCVDJQakNvZ3hDS2xQUEExQXVyeXBtdDJwX3dWalN0YWpiZHpZVURDMlF4YVJSQWhHc0lZWEp2V0ZINkY2SWlRSnBpcWllU3dEeG5lVWZVM055T1VYSFphejVhdV84NFlIVWM1dnJOR3BLRjRlVTVldkYtTDYxTHo1QQ?oc=5", "title": "Neurizon Therapeutics (ASX:NUZ)completes HEALEY ALS enrolment and brings NUZ-001 readout forward to 2027", "content_text": "Neurizon Therapeutics (ASX:NUZ)completes HEALEY ALS enrolment and brings NUZ-001 readout forward to 2027", "date_published": "2026-08-14T06:27:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "NUZ"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "NUZ", "name": "Neurizon Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/34d3fbdb-ab3e-4e73-9d4a-f674238a0199/"}]}}, {"id": "source:7ac18c82f5d2eb95c1ceee2b02e3089c62b83cd5efb1d438d656cd1394023660", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQdGtNbTVaNFRCRFZZUDI2WS02X3BZc09scDZHWkFSRVA5MEl0S3U5Umgza3E0NXBERjVfMTRaMW5FQ20tUWZ3V1h2ZldRX1pxREJOZmo4RGdwU2xmaTYtV1pELTY1UkhoX3ZPX0NJOWZvQVFialZYQWNENzBNa21ZMTZkNzNxSG1mNzJEaC1oR0lRMDlpR2ZPMnpPcmJ2NG8yWTFwOTd2dkhrank1Ul9wV0d0UXdmQnU4MnVrTXRkV1UxamZrdEE1cnl2ZjQ3MzdQNUR1QzFMdw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQdGtNbTVaNFRCRFZZUDI2WS02X3BZc09scDZHWkFSRVA5MEl0S3U5Umgza3E0NXBERjVfMTRaMW5FQ20tUWZ3V1h2ZldRX1pxREJOZmo4RGdwU2xmaTYtV1pELTY1UkhoX3ZPX0NJOWZvQVFialZYQWNENzBNa21ZMTZkNzNxSG1mNzJEaC1oR0lRMDlpR2ZPMnpPcmJ2NG8yWTFwOTd2dkhrank1Ul9wV0d0UXdmQnU4MnVrTXRkV1UxamZrdEE1cnl2ZjQ3MzdQNUR1QzFMdw?oc=5", "title": "Arovella Therapeutics Limited (ASX:ALA) Share Price Remains Unchanged as Stock Trades Within Daily Range", "content_text": "Arovella Therapeutics Limited (ASX:ALA) Share Price Remains Unchanged as Stock Trades Within Daily Range", "date_published": "2026-08-13T11:40:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ALA"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ALA", "name": "Arovella Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/56d90f95-88cc-4244-aa4a-01a32bf62238/"}]}}, {"id": "source:ef364579afbeb170beefe636aa5513aaeb94b63415bcd97bd9146e4e1497ff79", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNUkhaNFhreHYweUdTVVRGdWlIOXdhMjRpUWZIMk9TQXlPS0taZW1rcnBUTEZNOVJfU0FvVGJmVzJ3bGc5by1RbjhnM0ppZWNvWllPQmh6Q05SbEk4R0RXajF5NGt0ZmpDRkRLNFJGS2VFanRyVXNjdWZRWnd1YllYWnNFSHd4OHFRYlVaV25nTWNWTnd3NUQzdUh3dXBTeExhOGVhQW9OWndFU2duS0hfOE1oaWtNd01wb1FVaU83cVVwTl9mVjFmNFdOby0?oc=5", "external_url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNUkhaNFhreHYweUdTVVRGdWlIOXdhMjRpUWZIMk9TQXlPS0taZW1rcnBUTEZNOVJfU0FvVGJmVzJ3bGc5by1RbjhnM0ppZWNvWllPQmh6Q05SbEk4R0RXajF5NGt0ZmpDRkRLNFJGS2VFanRyVXNjdWZRWnd1YllYWnNFSHd4OHFRYlVaV25nTWNWTnd3NUQzdUh3dXBTeExhOGVhQW9OWndFU2duS0hfOE1oaWtNd01wb1FVaU83cVVwTl9mVjFmNFdOby0?oc=5", "title": "Argenica Therapeutics Limited (ASX:AGN) Share Price Falls 5.56% as Stock Trades Within Daily Range", "content_text": "Argenica Therapeutics Limited (ASX:AGN) Share Price Falls 5.56% as Stock Trades Within Daily Range", "date_published": "2026-08-13T11:40:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "AGN"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AGN", "name": "Argenica Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/83fc98f0-945a-4f13-be10-0cf6b715003b/"}]}}, {"id": "source:86d63b1e4d1820835bcc0d2591063f5f3db51a5182cf5d4be1248edc0ef43787", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNSVV5ZlByMjZLeTZEamFBT1pyWEE4RERGWTFkQ1AwLTJTQ1dfRnJ4RVpNeGU2MXlKbF8tMTIzLWtUbTB2bDNmMHFjRlBqMjZOWVo1RHdPVzgyZ3A3a21aVzlzWU9lc1FVMUVLSUNSdXFibmpmOXdSblBISVpCbk1sZ3BZdmNob3RueDl3N3BWTVlTeWlDSTJqMkVCYXhGWm1DVENYN3V1M3ZFREpBZUtiNWRINlRXeTFtaVNxX0I5dVlfbFRSeGl1RA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNSVV5ZlByMjZLeTZEamFBT1pyWEE4RERGWTFkQ1AwLTJTQ1dfRnJ4RVpNeGU2MXlKbF8tMTIzLWtUbTB2bDNmMHFjRlBqMjZOWVo1RHdPVzgyZ3A3a21aVzlzWU9lc1FVMUVLSUNSdXFibmpmOXdSblBISVpCbk1sZ3BZdmNob3RueDl3N3BWTVlTeWlDSTJqMkVCYXhGWm1DVENYN3V1M3ZFREpBZUtiNWRINlRXeTFtaVNxX0I5dVlfbFRSeGl1RA?oc=5", "title": "Amplia Therapeutics Limited (ASX:ATX) Share Price Rises 3.57% as Stock Trades Near Session High", "content_text": "Amplia Therapeutics Limited (ASX:ATX) Share Price Rises 3.57% as Stock Trades Near Session High", "date_published": "2026-08-13T11:36:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATX", "name": "Amplia Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/092cfe2d-9146-46c4-8b42-f095a50ab572/"}]}}, {"id": "source:b88d4d7f1f3d9460e32e53e1e0e21f857f33af8608b13d7d6921d7d9df622683", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNWmh5U0NucjZXVmlkUjAtMUFRV1cxWkZ1MjM5bDV3SzdfMnB2cGVMMGtHUFh4MjkxbzQxZzFKQWcyUTkycWx0VldUVlZQRU1mWE9kYkZzTFhEcHMtdWFrV1ZSRFhaeEdza181Ti05VTBCZ0hBbUhkYVdGOGtHX283bWd0TnV1VlFDNDFIdmhsdXBqVXpMdURXY3RmMFk3ZG0tUU44V21vM3R6bUo5ekxKLXZZejZ5M2ptaFVfOTBaRU5XODJOZDlPa0kyMmE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNWmh5U0NucjZXVmlkUjAtMUFRV1cxWkZ1MjM5bDV3SzdfMnB2cGVMMGtHUFh4MjkxbzQxZzFKQWcyUTkycWx0VldUVlZQRU1mWE9kYkZzTFhEcHMtdWFrV1ZSRFhaeEdza181Ti05VTBCZ0hBbUhkYVdGOGtHX283bWd0TnV1VlFDNDFIdmhsdXBqVXpMdURXY3RmMFk3ZG0tUU44V21vM3R6bUo5ekxKLXZZejZ5M2ptaFVfOTBaRU5XODJOZDlPa0kyMmE?oc=5", "title": "Alterity Therapeutics Limited (ASX:ATH) Share Price Falls 4.46% as Stock Trades Within Daily Range", "content_text": "Alterity Therapeutics Limited (ASX:ATH) Share Price Falls 4.46% as Stock Trades Within Daily Range", "date_published": "2026-08-13T11:32:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATH"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATH", "name": "Alterity Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/3bc01bec-3b89-43d1-b956-3676b3c6bd53/"}]}}, {"id": "source:ceb8d93a52ae7c72d4ee0febaec27d6493ab326e7b56b741590acb85c7dc5324", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPb0xJakRkRmlYYnFjczhXRGJhTURfeXJzS2lYdXRVbS1mS3p4WnFFOTgtU2RyaENRUkNVMS1UZDB0QkwtWnlDWnJiRlZTQmJYcGFTcHBpQVhGY0FULUlSNHJfNy1EelpvMURydUJuR25KYndjbmNNeWJ4QjRNQmp2cW9aNkxRcUkwSURHUjVOVWZFTnV5Q0RqSGlQaWd0MmJ3Z1JLZjFrM1A2bFFw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxPb0xJakRkRmlYYnFjczhXRGJhTURfeXJzS2lYdXRVbS1mS3p4WnFFOTgtU2RyaENRUkNVMS1UZDB0QkwtWnlDWnJiRlZTQmJYcGFTcHBpQVhGY0FULUlSNHJfNy1EelpvMURydUJuR25KYndjbmNNeWJ4QjRNQmp2cW9aNkxRcUkwSURHUjVOVWZFTnV5Q0RqSGlQaWd0MmJ3Z1JLZjFrM1A2bFFw?oc=5", "title": "Actinogen Medical Ltd (ASX: ACW) Share Price Steady as Stock Closes Flat", "content_text": "Actinogen Medical Ltd (ASX: ACW) Share Price Steady as Stock Closes Flat", "date_published": "2026-08-13T11:32:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ACW"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ACW", "name": "Actinogen Medical Limited", "sentiment_url": "https://sharemaestro.com/sentiment/aabbf5e9-c8ed-46f9-8126-2ce2b36e90a5/"}]}}, {"id": "source:43bff6743632728b026308fa6f57c957fa99e86b0e32eece3bf3d8fbf6e79f8a", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNMEl5ZXdfT09IYzhVQ0ZRQU1wQjVVTnJVSUtHWGdEdFY1cXJ5NEVDMFJiV0pTWmdmelFtM1hTQ1RhcDI1M1J6cHE1X3Vock5ScmhjYkdnR3RzSWdvbDhIUVM1eV9Md2pfUzlHMGJ5YVBPY180dE9kS3JqRDJwNDhaY0FCSXZkMjNyWElkTUhqdEtJbHRzRkdYcEwtY0xIRVBNeTNVbUtsVjVLOGRtbEhWUHFmYWliVFlUOHdQdWJrLTNzZjhERFM2X2RQZmV4ZFZOd244Wg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNMEl5ZXdfT09IYzhVQ0ZRQU1wQjVVTnJVSUtHWGdEdFY1cXJ5NEVDMFJiV0pTWmdmelFtM1hTQ1RhcDI1M1J6cHE1X3Vock5ScmhjYkdnR3RzSWdvbDhIUVM1eV9Md2pfUzlHMGJ5YVBPY180dE9kS3JqRDJwNDhaY0FCSXZkMjNyWElkTUhqdEtJbHRzRkdYcEwtY0xIRVBNeTNVbUtsVjVLOGRtbEhWUHFmYWliVFlUOHdQdWJrLTNzZjhERFM2X2RQZmV4ZFZOd244Wg?oc=5", "title": "Radiopharm Theranostics Calls Virtual Extraordinary General Meeting for September 2026", "content_text": "Radiopharm Theranostics Calls Virtual Extraordinary General Meeting for September 2026", "date_published": "2026-08-13T11:00:56+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "RAD"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "RAD", "name": "Radiopharm Theranostics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/4df94284-1220-420e-a52a-fb738f3845e7/"}]}}, {"id": "source:edefec4f0573c83413579453b6216ff20742fafe96f9b80b9179b24a0c1ee0f2", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPeHFCaWd4S2tILUx0TmxwOFN3MWJVRWpnYlVvUk1nWWw3Tmllb1hUMVcwazJWemNvVkN2N0NnSkRIaHJnd19fVDBHejlvTkRkN2E0VDVYM09fZWp4aDVKWkZyRmFtb2ctakY5eHVpWEZxR0x5eDVmQjFJczM0bWRrVDZUZkZzZ2MxR2U5bEpad3dPd3EyVWR2eExVYkNDa2ZseVFPUzBFT19ZV1lady05bDlQblpMTTl1d3NrSDNR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPeHFCaWd4S2tILUx0TmxwOFN3MWJVRWpnYlVvUk1nWWw3Tmllb1hUMVcwazJWemNvVkN2N0NnSkRIaHJnd19fVDBHejlvTkRkN2E0VDVYM09fZWp4aDVKWkZyRmFtb2ctakY5eHVpWEZxR0x5eDVmQjFJczM0bWRrVDZUZkZzZ2MxR2U5bEpad3dPd3EyVWR2eExVYkNDa2ZseVFPUzBFT19ZV1lady05bDlQblpMTTl1d3NrSDNR?oc=5", "title": "Telix Pharmaceuticals (TLX) to Release Quarterly Earnings on Thursday", "content_text": "Telix Pharmaceuticals (TLX) to Release Quarterly Earnings on Thursday", "date_published": "2026-08-13T06:00:28+00:00", "authors": [{"name": "MarketBeat"}], "tags": ["Earnings", "TLX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "TLX", "name": "Telix Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/dfe56e32-81f8-4afe-ad4b-c7fd114234a5/"}]}}, {"id": "source:ca38a62a95c021b32157ddf756af5f9f5ecbe46ec1b4ea3f2b5ef3e35cf768e2", "url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxOdjFkbnp6NzNuTDZqMllEVnkxcDJ6OFlLRzhuQ1FIVnd0N2FmSGNuWGdQQ2RfbzZkM19WTnVJUzZ5VjlnaS15NmdTQm5kVmY2WkJFR0RtNDNaM19rYURfYlc2QU1tajFZNmVYT0ZycDg4Vi1US0lBSExVaTAwSzAweG01enZmRzlFVU55YXp3YjZlQmE2Y2NyR0o0TzA2RHRVd25mbGdtNGZtUGNmdXBZVHhwOE1LY2hvcW1oaFZ4cEU4RGtnaDJtaUo4TTVFUVh5cl9XNzlST1BhU1BvaDZuRVlocTFwX1l3?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi6AFBVV95cUxOdjFkbnp6NzNuTDZqMllEVnkxcDJ6OFlLRzhuQ1FIVnd0N2FmSGNuWGdQQ2RfbzZkM19WTnVJUzZ5VjlnaS15NmdTQm5kVmY2WkJFR0RtNDNaM19rYURfYlc2QU1tajFZNmVYT0ZycDg4Vi1US0lBSExVaTAwSzAweG01enZmRzlFVU55YXp3YjZlQmE2Y2NyR0o0TzA2RHRVd25mbGdtNGZtUGNmdXBZVHhwOE1LY2hvcW1oaFZ4cEU4RGtnaDJtaUo4TTVFUVh5cl9XNzlST1BhU1BvaDZuRVlocTFwX1l3?oc=5", "title": "Racura Oncology Ltd (ASX:RAC) Falls \u2014 Is the Company Formerly Known as Race Oncology Facing Its First Big Investor Test?", "content_text": "Racura Oncology Ltd (ASX:RAC) Falls \u2014 Is the Company Formerly Known as Race Oncology Facing Its First Big Investor Test?", "date_published": "2026-08-12T10:47:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "RAC"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "RAC", "name": "Racura Oncology Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/352ad92c-a187-4af9-b30c-507ada633040/"}]}}, {"id": "source:85bf9d61ebd941309ccc35b0177396fc2b21569779221809ed34c95ec3b006e1", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOVnZoLUJTSVVpdUZmTDQtMEVTWXVTdDlOOXBDSUlFUVVZR2JzMVZ1WWRCOV8yNV9zRnYtTU9ZSTItZDM5UTNjN3JLbVJEWUJmd0J3Z2ltcFJLS2FNZFE2QnFxWXZZRElXelRjQUVOVGxEdkZNdUpDOEF6UndJOW5KZkI4S1NfcG5LVnlYcjg0NnpkcEo0NkUwWjJwZ1FCRXllTWhLSHV6N3pER3JPXzZhWFRyTGhmZHlRSUQ3bUg5SXRqak8zRWx3OC1VRXhoMUFDZkpUX2FnUW04TFJwNTVR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxOVnZoLUJTSVVpdUZmTDQtMEVTWXVTdDlOOXBDSUlFUVVZR2JzMVZ1WWRCOV8yNV9zRnYtTU9ZSTItZDM5UTNjN3JLbVJEWUJmd0J3Z2ltcFJLS2FNZFE2QnFxWXZZRElXelRjQUVOVGxEdkZNdUpDOEF6UndJOW5KZkI4S1NfcG5LVnlYcjg0NnpkcEo0NkUwWjJwZ1FCRXllTWhLSHV6N3pER3JPXzZhWFRyTGhmZHlRSUQ3bUg5SXRqak8zRWx3OC1VRXhoMUFDZkpUX2FnUW04TFJwNTVR?oc=5", "title": "Arovella Therapeutics Hosts Investor Webinar on iNKT Cell Therapy Platform and ALA-101 Clinical Progress", "content_text": "Arovella Therapeutics Hosts Investor Webinar on iNKT Cell Therapy Platform and ALA-101 Clinical Progress", "date_published": "2026-08-12T03:14:11+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ALA"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ALA", "name": "Arovella Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/56d90f95-88cc-4244-aa4a-01a32bf62238/"}]}}, {"id": "source:0e6507f5f6bf7b638b8e403daa3ed5c3b4d2d5b83f98ff1ae591b04bc9e4842a", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Telix Pharmaceuticals Stock Leads This ASX Growth Screen With Strong Insider Backing", "content_text": "Telix Pharmaceuticals Stock Leads This ASX Growth Screen With Strong Insider Backing", "date_published": "2026-08-11T21:42:33+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Market update", "TLX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "TLX", "name": "Telix Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/dfe56e32-81f8-4afe-ad4b-c7fd114234a5/"}]}}, {"id": "source:03ea0373703cd4b42c5cacf7004355e8ff04b44e253e409c75b2ced35ec1d8cb", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPcXNwVEZwZGNkeXNZQUM2QnJWY05HaHByY3RFMlJCY1ZJMUxfei1HQ3hfb3RZcE5sUTRjZFFrSVVZWENFZGlNbEpEUzdBeHd4ZGZOVlhpU0k3dTNwTTd4X2haTGNtVWN1Q1c2d2xqcVZJXzNhVlo2QUpaQ2pwOVRQcHFvUkMwbWcwZU5BeXNlNFFPa05XVjZ3UjF3Zm9hYjZpaUtwdFRpSkxhUXNyTVBvTDc4dDdXVG1sQWVpZ2M4c3FMM1lpbEE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxPcXNwVEZwZGNkeXNZQUM2QnJWY05HaHByY3RFMlJCY1ZJMUxfei1HQ3hfb3RZcE5sUTRjZFFrSVVZWENFZGlNbEpEUzdBeHd4ZGZOVlhpU0k3dTNwTTd4X2haTGNtVWN1Q1c2d2xqcVZJXzNhVlo2QUpaQ2pwOVRQcHFvUkMwbWcwZU5BeXNlNFFPa05XVjZ3UjF3Zm9hYjZpaUtwdFRpSkxhUXNyTVBvTDc4dDdXVG1sQWVpZ2M4c3FMM1lpbEE?oc=5", "title": "Arovella Therapeutics Limited (ASX:ALA) Share Market Overview and Healthcare Sector Profile", "content_text": "Arovella Therapeutics Limited (ASX:ALA) Share Market Overview and Healthcare Sector Profile", "date_published": "2026-08-11T13:18:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ALA"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ALA", "name": "Arovella Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/56d90f95-88cc-4244-aa4a-01a32bf62238/"}]}}, {"id": "source:4e6801f5c4c49521ee50ee0dafda4a13dcd6ce9d1952d5f9f9078cd36cb137c0", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNX0lrY2Z5Z0FzT19RTXh1RENOcGhqN1hEUlduYlBrZDU0eUFuWFNQRXEtYXU3RlNxV2wzT0wwX3VOa1RNd2pZTWdJdmJGT2JsUVdTTjFNaXVBWElyRDdkeUtYSGVoSVhRaFd0LUVucFFoaHlvTUpNZzFNb0ZGZXBIbDdCWjY1ZURXNlQtNjE2WVdKdllnVWpKQ3hxaVVJb1hOTnYzZk5pSlh4YmxyQnBhaFF5RzRnMVA2ck1ZUU5rM3BCZw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxNX0lrY2Z5Z0FzT19RTXh1RENOcGhqN1hEUlduYlBrZDU0eUFuWFNQRXEtYXU3RlNxV2wzT0wwX3VOa1RNd2pZTWdJdmJGT2JsUVdTTjFNaXVBWElyRDdkeUtYSGVoSVhRaFd0LUVucFFoaHlvTUpNZzFNb0ZGZXBIbDdCWjY1ZURXNlQtNjE2WVdKdllnVWpKQ3hxaVVJb1hOTnYzZk5pSlh4YmxyQnBhaFF5RzRnMVA2ck1ZUU5rM3BCZw?oc=5", "title": "Amplia Therapeutics Ltd (ASX:ATX) Share Price Update: Trading Snapshot for 11 August 2026", "content_text": "Amplia Therapeutics Ltd (ASX:ATX) Share Price Update: Trading Snapshot for 11 August 2026", "date_published": "2026-08-11T13:13:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATX", "name": "Amplia Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/092cfe2d-9146-46c4-8b42-f095a50ab572/"}]}}, {"id": "source:518541f6f3649c149b9e39bbe0e221bec4e4486b008ab50aee4f519ac7125694", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNTEhycmh1UDVCdWV0bG52amxrTkpFRElEV04ySW93aTBnN09PZVY3cUtTaGpGM3hDSWlFQ1RLMjB6ZzhFaXNYOGFxSFBBYjF3eGRxSnJaVFpwYVRkMjhja3FrMy1WRmFVM2p3cEF0aG0zNVVVSkx4R1NYejU2OVh1d0RSeEFKb1RQNi14MEw3ZF9rSWp5aUN2Qkp4QjVQYk5tVExrajlVUlE5VXJKSVB5RlJYNk1QZw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNTEhycmh1UDVCdWV0bG52amxrTkpFRElEV04ySW93aTBnN09PZVY3cUtTaGpGM3hDSWlFQ1RLMjB6ZzhFaXNYOGFxSFBBYjF3eGRxSnJaVFpwYVRkMjhja3FrMy1WRmFVM2p3cEF0aG0zNVVVSkx4R1NYejU2OVh1d0RSeEFKb1RQNi14MEw3ZF9rSWp5aUN2Qkp4QjVQYk5tVExrajlVUlE5VXJKSVB5RlJYNk1QZw?oc=5", "title": "Clarity Pharmaceuticals (ASX:CU6) Rises As SECuRE Trial Delivers More Responses", "content_text": "Clarity Pharmaceuticals (ASX:CU6) Rises As SECuRE Trial Delivers More Responses", "date_published": "2026-08-10T13:42:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "CU6"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CU6", "name": "Clarity Pharmaceuticals Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/5c03ba20-9b97-4e8a-9694-bfae1208f6d8/"}]}}, {"id": "source:c2c792442aac987cacfaf334130ddaf2b3b7d098c575b7b3546277087c73051c", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPNWp1eDcyOTdRd00zaHlwc2JOMWJLLUVUWHNQUWtOZWIwSnhBaGNWTXNCWWQzeDNsTjZxSTRodlIySWR2UzZQRVBORGo0U01nblJXOG54STVxMUlEcFBsSjlFa0Z3Y2JVYjQ2UkNsUDMxN2tXS2xoSTFCSkQtN0lhcG9ST0o5bXFiM3I1R3FUNWVwWGhqZXVrdndyRWM2MUEtd2sxYTEydXRLV3FBc3VwYlRHMEZMQQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxPNWp1eDcyOTdRd00zaHlwc2JOMWJLLUVUWHNQUWtOZWIwSnhBaGNWTXNCWWQzeDNsTjZxSTRodlIySWR2UzZQRVBORGo0U01nblJXOG54STVxMUlEcFBsSjlFa0Z3Y2JVYjQ2UkNsUDMxN2tXS2xoSTFCSkQtN0lhcG9ST0o5bXFiM3I1R3FUNWVwWGhqZXVrdndyRWM2MUEtd2sxYTEydXRLV3FBc3VwYlRHMEZMQQ?oc=5", "title": "Amplia Therapeutics (ASX:ATX) Firms As Market Watches Pancreatic Cancer Program", "content_text": "Amplia Therapeutics (ASX:ATX) Firms As Market Watches Pancreatic Cancer Program", "date_published": "2026-08-10T13:39:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATX", "name": "Amplia Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/092cfe2d-9146-46c4-8b42-f095a50ab572/"}]}}, {"id": "source:f4548c55a2441b69f2c121c02a2bd0a9a91c61d097b65c91f724db7a55bb0c6a", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNWTZjZk5WX2NGaHdmM1VzVFlNOF9yMzZIZk9mMHRQcElKTXZzQ0JfVG9jWGhKTFJmdUNZMEtmb2pKWm91V04ySkxJYUlhbHliVkVCSW9aLVNIbWtueEVoOVNnanhGLXk3RWxqR3dCUWdGUUN6R002MGhzRFNGdzhwZV9Ha0NGSW9udXhXbHBhWjhwZVNuTGE2ZkxxV1JJM1R0Z2NuSlBSMGk3QXgtVE95aDJR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxNWTZjZk5WX2NGaHdmM1VzVFlNOF9yMzZIZk9mMHRQcElKTXZzQ0JfVG9jWGhKTFJmdUNZMEtmb2pKWm91V04ySkxJYUlhbHliVkVCSW9aLVNIbWtueEVoOVNnanhGLXk3RWxqR3dCUWdGUUN6R002MGhzRFNGdzhwZV9Ha0NGSW9udXhXbHBhWjhwZVNuTGE2ZkxxV1JJM1R0Z2NuSlBSMGk3QXgtVE95aDJR?oc=5", "title": "Alterity Therapeutics (ASX:ATH) Rises As ATH434 Moves Toward Pivotal Phase 3", "content_text": "Alterity Therapeutics (ASX:ATH) Rises As ATH434 Moves Toward Pivotal Phase 3", "date_published": "2026-08-10T13:39:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATH"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATH", "name": "Alterity Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/3bc01bec-3b89-43d1-b956-3676b3c6bd53/"}]}}, {"id": "source:2ef39042bfbb8c6a7e090ae1fff6ec0d1d5f1a115ccdcee475a70bd1bad0dc1b", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQaDF1cUQySTJub0hQNzBxSWd5ZHpBSDQybGNhcTlhMnhxV1hXZ2tpZm5UQkZTOURPaVdDZ3BFQ05UUi1oNkExdkNjdVpkd005ZXc2RlFBemp6VV80YmMzSVRaaUN4ZW1HTVJTdVdtbEpUaUlDOG5rN1NObEQxWi15MFA3RjhLMVZiMFVoYm1FX0w5YTNxcDhkOVliN3pGNXdhdGhDM3hFZHhNTzBhQkFMTExkT1I1WUh5MHJJ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxQaDF1cUQySTJub0hQNzBxSWd5ZHpBSDQybGNhcTlhMnhxV1hXZ2tpZm5UQkZTOURPaVdDZ3BFQ05UUi1oNkExdkNjdVpkd005ZXc2RlFBemp6VV80YmMzSVRaaUN4ZW1HTVJTdVdtbEpUaUlDOG5rN1NObEQxWi15MFA3RjhLMVZiMFVoYm1FX0w5YTNxcDhkOVliN3pGNXdhdGhDM3hFZHhNTzBhQkFMTExkT1I1WUh5MHJJ?oc=5", "title": "Actinogen Medical Tightens Trading Rules With New Governance Policy", "content_text": "Actinogen Medical Tightens Trading Rules With New Governance Policy", "date_published": "2026-08-10T07:03:40+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "ACW"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ACW", "name": "Actinogen Medical Limited", "sentiment_url": "https://sharemaestro.com/sentiment/aabbf5e9-c8ed-46f9-8126-2ce2b36e90a5/"}]}}, {"id": "source:36f22c716bfd09640afd45d8268c2c151d202effcc512b64ec1bf8c735754b4d", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOaVhSNzNuNVJrQjhtTHVuWmRHM3hLWm84S3FjMEhJZnpWcFRaWFYxUE05a0MxbF9vODN2Y1Z4UmJCY2R5Q2FUa2VhTXhEVDVndDRsZlpCNWUyNl9Edmt0R3RGaUlsRGk5QXY4OF9LUXpISW03LUFmYlluaEktQVVKaFhVc2FUTHNsRDREZVN1eW92N0xqVzRjQnl0cw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxOaVhSNzNuNVJrQjhtTHVuWmRHM3hLWm84S3FjMEhJZnpWcFRaWFYxUE05a0MxbF9vODN2Y1Z4UmJCY2R5Q2FUa2VhTXhEVDVndDRsZlpCNWUyNl9Edmt0R3RGaUlsRGk5QXY4OF9LUXpISW03LUFmYlluaEktQVVKaFhVc2FUTHNsRDREZVN1eW92N0xqVzRjQnl0cw?oc=5", "title": "Could Actinogen Medical\u2019s (ASX:ACW) New Shares Matter?", "content_text": "Could Actinogen Medical\u2019s (ASX:ACW) New Shares Matter?", "date_published": "2026-08-10T02:02:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "ACW"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ACW", "name": "Actinogen Medical Limited", "sentiment_url": "https://sharemaestro.com/sentiment/aabbf5e9-c8ed-46f9-8126-2ce2b36e90a5/"}]}}, {"id": "source:279a56fab9362af4d30a523470dd1983b86deedbb8d2567344c44ad09012c2e0", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQOURIdnFNaTZBY3N5cG1UUVZyNFZlenY5dDNVTl9IRUlPZjZIZGRKeFlMS3B2djFvcXFYNjU1V0R6NHpHcHZEY3JYT0FyRm1acXpVc0dWYTd2YUM3a3pOa19qWG54Z2pIV0xHSy1heFB6bWQ5NzAzRkJyeDBocHNnS1pmVzFlUExaV21ENUZiNWQ0UnJhVTVYRTVUTzZmRWlrb284bElJNXVOaGhlTWRXOA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQOURIdnFNaTZBY3N5cG1UUVZyNFZlenY5dDNVTl9IRUlPZjZIZGRKeFlMS3B2djFvcXFYNjU1V0R6NHpHcHZEY3JYT0FyRm1acXpVc0dWYTd2YUM3a3pOa19qWG54Z2pIV0xHSy1heFB6bWQ5NzAzRkJyeDBocHNnS1pmVzFlUExaV21ENUZiNWQ0UnJhVTVYRTVUTzZmRWlrb284bElJNXVOaGhlTWRXOA?oc=5", "title": "Actinogen Medical Seeks ASX Quotation for Additional Shares", "content_text": "Actinogen Medical Seeks ASX Quotation for Additional Shares", "date_published": "2026-08-10T01:51:21+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "ACW"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ACW", "name": "Actinogen Medical Limited", "sentiment_url": "https://sharemaestro.com/sentiment/aabbf5e9-c8ed-46f9-8126-2ce2b36e90a5/"}]}}, {"id": "source:c2217bb9a404e1d60a820e21feb090cc58191b5a95195f6e0a06f48b9227e303", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQTmtwWWxDVERiLUtsN2cyRGxuLW00RnhkOUlWLUE0OE9xMkVtUkFVLUlJLS1xY2lBX1JZNjgxTjFnY3NhUlNpRmZaUDA0VnJRMGY4ZlNTRjdXenVBWkFHUmZuQ2pxck5sbDVTNmMzTjRjRTEwM2tQRUtsaGw1eTFnUGNHLVF2WndBa3pFcVlXaHRmS01pVm1MNlpUTEpjaEoxcHBaV1NjcFJDVkRwbjdHd0lycU4tVVFGNG1YcjJwdUotZ00?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQTmtwWWxDVERiLUtsN2cyRGxuLW00RnhkOUlWLUE0OE9xMkVtUkFVLUlJLS1xY2lBX1JZNjgxTjFnY3NhUlNpRmZaUDA0VnJRMGY4ZlNTRjdXenVBWkFHUmZuQ2pxck5sbDVTNmMzTjRjRTEwM2tQRUtsaGw1eTFnUGNHLVF2WndBa3pFcVlXaHRmS01pVm1MNlpUTEpjaEoxcHBaV1NjcFJDVkRwbjdHd0lycU4tVVFGNG1YcjJwdUotZ00?oc=5", "title": "Why Have Clinuvel Pharmaceuticals (ASX:CUV) Shares Fallen Despite Recent Clinical Updates?", "content_text": "Why Have Clinuvel Pharmaceuticals (ASX:CUV) Shares Fallen Despite Recent Clinical Updates?", "date_published": "2026-08-09T07:00:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "CUV"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CUV", "name": "Clinuvel Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/04c1ac47-688d-4400-a389-c61c1fd17b1a/"}]}}, {"id": "source:4f1b0e0c248da30cad1d95b753c7d70275b33fe87adbf95016794e6c8c7022b8", "url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE12SkFpZmU0VXNNYXlEblItTGN6d09OcTUzSjJ0cVNSeHhfWllNc0NWY3JqTG9lTG53ZWN4cGlIVm5FSWk0WWYxbzVMTFd2Mktic2FKSVVrN1gtZHBab3V0SG5WdVNnUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiZkFVX3lxTE12SkFpZmU0VXNNYXlEblItTGN6d09OcTUzSjJ0cVNSeHhfWllNc0NWY3JqTG9lTG53ZWN4cGlIVm5FSWk0WWYxbzVMTFd2Mktic2FKSVVrN1gtZHBab3V0SG5WdVNnUQ?oc=5", "title": "Immutep Ltd (IMMP) Earnings Forecast: Future EPS & Revenue Growth Estimates", "content_text": "Immutep Ltd (IMMP) Earnings Forecast: Future EPS & Revenue Growth Estimates", "date_published": "2026-08-07T18:18:29+00:00", "authors": [{"name": "TradingKey"}], "tags": ["Earnings", "IMM"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "IMM", "name": "Immutep Limited", "sentiment_url": "https://sharemaestro.com/sentiment/5acd28d1-e9da-4477-b9cd-96f8a1f7f5f3/"}]}}, {"id": "source:afe9edb70ab8774b35a09a6ebdb9dd2c203ab7b2925815540022ba3d750fb919", "url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPQ0JBZWpwR1FadlJrQkp0TUlLR3hpd2xtaXpIR1N5OGE4WEtDN1ZoZzZ6NUwxNzZuUTlJc3FnRkl6S2JBSGs1blZLaHdUZzZSQXlRVEVrTE5jeER5NVptVE5aNTV0dUVLVlZGdGhYWF9BXzJaNmROV0NlMzhyQV9fdWkzUk9LYUt6Yzh6OHBYSVh0NVRJaGdoQzF0M09xMGVEOWFjLTFSbmFPZTNWUEVJVEV1V0FZMlVXTm14bGFwNERCMmlqZU9CQjgzNVpXaUN5UUI0?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPQ0JBZWpwR1FadlJrQkp0TUlLR3hpd2xtaXpIR1N5OGE4WEtDN1ZoZzZ6NUwxNzZuUTlJc3FnRkl6S2JBSGs1blZLaHdUZzZSQXlRVEVrTE5jeER5NVptVE5aNTV0dUVLVlZGdGhYWF9BXzJaNmROV0NlMzhyQV9fdWkzUk9LYUt6Yzh6OHBYSVh0NVRJaGdoQzF0M09xMGVEOWFjLTFSbmFPZTNWUEVJVEV1V0FZMlVXTm14bGFwNERCMmlqZU9CQjgzNVpXaUN5UUI0?oc=5", "title": "Arovella Therapeutics Ltd (ASX: ALA) Share Price Update: Stock Rises as Health Care Index Closes Lower", "content_text": "Arovella Therapeutics Ltd (ASX: ALA) Share Price Update: Stock Rises as Health Care Index Closes Lower", "date_published": "2026-08-07T13:43:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ALA"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ALA", "name": "Arovella Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/56d90f95-88cc-4244-aa4a-01a32bf62238/"}]}}, {"id": "source:19de58fec640e351fe2cabdac212a470b1678787436895211b819a77b68ed053", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNTHVjMVpzdTkydURJVjlxSzlqTGFwRUtoVW83My15VXhEdlNDY25kT1RJWDhxQ2ZQLW5Kd2IyNXBUMFQxYjNwMkxLV1czSTRRR3lGWmR2TnYtd25OVFZJaWt2eVJ4YV9CTUZFbEpfUW5tdmdQR0VYZldmaU9La0tBRkFRNmU0ZmZDRVdHelVUeDROQS13dHo3RDRReGtIQ0xyMHJxblFzTlg2YTljVmtQT0xuZTMtMDJsT2g1dlJPOG15OURoS043aGNsTlhZMjZOTnJURA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNTHVjMVpzdTkydURJVjlxSzlqTGFwRUtoVW83My15VXhEdlNDY25kT1RJWDhxQ2ZQLW5Kd2IyNXBUMFQxYjNwMkxLV1czSTRRR3lGWmR2TnYtd25OVFZJaWt2eVJ4YV9CTUZFbEpfUW5tdmdQR0VYZldmaU9La0tBRkFRNmU0ZmZDRVdHelVUeDROQS13dHo3RDRReGtIQ0xyMHJxblFzTlg2YTljVmtQT0xuZTMtMDJsT2g1dlJPOG15OURoS043aGNsTlhZMjZOTnJURA?oc=5", "title": "Argenica Therapeutics Ltd (ASX: AGN) Share Price Update: Stock Rises as Health Care Sector Closes Lower", "content_text": "Argenica Therapeutics Ltd (ASX: AGN) Share Price Update: Stock Rises as Health Care Sector Closes Lower", "date_published": "2026-08-07T13:43:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "AGN"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "AGN", "name": "Argenica Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/83fc98f0-945a-4f13-be10-0cf6b715003b/"}]}}, {"id": "source:bfa1fe6aef22f8edb549e23a5ed314de142848124d3e055d1c891a6cff3777e0", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxNaVhLWUVvUVF1UlRsaUlJbEM5UFR4TWxJRzNoRFowUnByV29QckRPVkR5aDROV0Y3UWJDemxpR2hvMDVUeVJLcjJTNm9hX1pqc1VlZ3RLYkoyczJWWHctVmZVR2xqTUUxTFpxZUNTeTRfN21MUU1lVGdPM2hHazFDRVowQzJLYWVIRzc3aWk5MGZfOEY5bTh2eUphc25qRGlEU2YzLUphMklMMnhTa2l5VzE0Yk5ESFBSVXpCZjRwak5NXzdRaWRET1p0aGdTZzc2ZGJEZlkyUWl0eWIxX19DeUpodVZ1bmNXWmhV?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxNaVhLWUVvUVF1UlRsaUlJbEM5UFR4TWxJRzNoRFowUnByV29QckRPVkR5aDROV0Y3UWJDemxpR2hvMDVUeVJLcjJTNm9hX1pqc1VlZ3RLYkoyczJWWHctVmZVR2xqTUUxTFpxZUNTeTRfN21MUU1lVGdPM2hHazFDRVowQzJLYWVIRzc3aWk5MGZfOEY5bTh2eUphc25qRGlEU2YzLUphMklMMnhTa2l5VzE0Yk5ESFBSVXpCZjRwak5NXzdRaWRET1p0aGdTZzc2ZGJEZlkyUWl0eWIxX19DeUpodVZ1bmNXWmhV?oc=5", "title": "Amplia Therapeutics Ltd (ASX: ATX) Share Price Update: Trading Activity and Biotechnology Sector Trends on August 7, 2026", "content_text": "Amplia Therapeutics Ltd (ASX: ATX) Share Price Update: Trading Activity and Biotechnology Sector Trends on August 7, 2026", "date_published": "2026-08-07T07:21:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATX", "name": "Amplia Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/092cfe2d-9146-46c4-8b42-f095a50ab572/"}]}}, {"id": "source:20e2ecd55c5a77c18497eddb7a5f1e61eaa3f6aefe46e30b810b230e695d5f4b", "url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxObzB5Y0FoYXZzRkxEZ1ZOV3dZZktvcVVadXBHTmR6eEZwa2pMVWFLUnhYSml1eW9RWTBPT3RhQlFhOHAyMlRBSE5kWTZQemdsT0U0b2xpRUUweXhvN2ZPX1lCRk92aFhObGxsVWtacHVYVzNxMElOVm4yb0QwYTA4VUVGTnc5YnZuOGRVOTVFcUJsNThDbFBFaTZFNzZxOS1aVmVINkN4TGM1X2dyT09yVWZHZ2xpMWtZWHdhbVVRVEJoYy1QNFhiYkR3cjVUcXBjVFo2Ym5MNE9NblIzeENfZlNRTVp2ODFwSmUw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi6wFBVV95cUxObzB5Y0FoYXZzRkxEZ1ZOV3dZZktvcVVadXBHTmR6eEZwa2pMVWFLUnhYSml1eW9RWTBPT3RhQlFhOHAyMlRBSE5kWTZQemdsT0U0b2xpRUUweXhvN2ZPX1lCRk92aFhObGxsVWtacHVYVzNxMElOVm4yb0QwYTA4VUVGTnc5YnZuOGRVOTVFcUJsNThDbFBFaTZFNzZxOS1aVmVINkN4TGM1X2dyT09yVWZHZ2xpMWtZWHdhbVVRVEJoYy1QNFhiYkR3cjVUcXBjVFo2Ym5MNE9NblIzeENfZlNRTVp2ODFwSmUw?oc=5", "title": "Alterity Therapeutics Ltd (ASX: ATH) Share Price Update: Stock Movement and Biotechnology Sector Trends on August 7, 2026", "content_text": "Alterity Therapeutics Ltd (ASX: ATH) Share Price Update: Stock Movement and Biotechnology Sector Trends on August 7, 2026", "date_published": "2026-08-07T07:21:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATH"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATH", "name": "Alterity Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/3bc01bec-3b89-43d1-b956-3676b3c6bd53/"}]}}, {"id": "source:f6e84727f3d854ef29b43a757131e25fab9e42365d020268c60214c6970fe7c2", "url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxOMFF5X0J5alpzdW9DdGRiTTJYN1k5a2VuRHB0TjlYa2NsdE1tN2hsekI4VmZnWkxsRUhhYkJtNEc2WUZsSC1FY2U1cUx4alhlcHNWaHh5RlVwX19ZaWpFSUg2eE9sVkl5SzdNSHQ3OXdzTmNyV0cxNHNjVjFSNzZBUk40NVp6Q3Azcnk5U0hyYVpOM0ZSd0tLcWFiY0Fsbmx3TVZjc0RKZnduTEs3SldTR2NldFFYT0xjWFBJZGp6YTN0czlvRTdxLXNBZlVMRWZtVXpyeElaS01QT0VuTnNNYmpVSzlydjlBNUhha3lR?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi7gFBVV95cUxOMFF5X0J5alpzdW9DdGRiTTJYN1k5a2VuRHB0TjlYa2NsdE1tN2hsekI4VmZnWkxsRUhhYkJtNEc2WUZsSC1FY2U1cUx4alhlcHNWaHh5RlVwX19ZaWpFSUg2eE9sVkl5SzdNSHQ3OXdzTmNyV0cxNHNjVjFSNzZBUk40NVp6Q3Azcnk5U0hyYVpOM0ZSd0tLcWFiY0Fsbmx3TVZjc0RKZnduTEs3SldTR2NldFFYT0xjWFBJZGp6YTN0czlvRTdxLXNBZlVMRWZtVXpyeElaS01QT0VuTnNNYmpVSzlydjlBNUhha3lR?oc=5", "title": "Actinogen Medical Ltd (ASX: ACW) Share Price Update: Stock Records Higher Trading Session Amid Health Care Sector Weakness", "content_text": "Actinogen Medical Ltd (ASX: ACW) Share Price Update: Stock Records Higher Trading Session Amid Health Care Sector Weakness", "date_published": "2026-08-07T07:20:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ACW"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ACW", "name": "Actinogen Medical Limited", "sentiment_url": "https://sharemaestro.com/sentiment/aabbf5e9-c8ed-46f9-8126-2ce2b36e90a5/"}]}}, {"id": "source:b5db779f494d6236d8a922a15cec26ef9ac6139144977548f11f97e276770b32", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNaVFVU01DcjhjVnlVc1FPZlg4YTFPMEo3eEpCMVJPY3FZdElhTFdNdElEam1SS3BmS0k0YjhTZkZtMGNPYWxMaHcyQWZfMjR5cUJOVUsxZjgzdzFrMUIzYjRXdUw3NmNmblM5TjJGa21vNW9XS0ZmUXg2R2FhajN5aWE0eTlIV3EyVWVnRmRjVjZhMjEzZE1jSHZNTDlLRTNrX3E4YmgzTDVjbkhNeUM2eUNpZm0tWFloVU9RMmtn?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNaVFVU01DcjhjVnlVc1FPZlg4YTFPMEo3eEpCMVJPY3FZdElhTFdNdElEam1SS3BmS0k0YjhTZkZtMGNPYWxMaHcyQWZfMjR5cUJOVUsxZjgzdzFrMUIzYjRXdUw3NmNmblM5TjJGa21vNW9XS0ZmUXg2R2FhajN5aWE0eTlIV3EyVWVnRmRjVjZhMjEzZE1jSHZNTDlLRTNrX3E4YmgzTDVjbkhNeUM2eUNpZm0tWFloVU9RMmtn?oc=5", "title": "Entropy Neurodynamics Boosts Director Equity Through Share-Based Fees", "content_text": "Entropy Neurodynamics Boosts Director Equity Through Share-Based Fees", "date_published": "2026-08-07T05:27:23+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "ENP"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ENP", "name": "Entropy Neurodynamics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/05ff8d4a-05f2-4a21-9c2f-f7d132822d6d/"}]}}, {"id": "source:d8a38c2a0287e4dbc2678f0abc9892c51879abf0d7342f606a2e6fc1e5c2a7ab", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOGJ6U084Y2J3VlBnNndQbV9BRkc5eHlOdzBPY09nVUt3TEkyTVozQ3NEV0JrN3dCNG4wUGNpc0hQNi1UMGZtcGN6QU1Nc0xQMEN0amZxUTNaemhzTEI5bkJJVU90ZElHZXQ0Q1F0bUI2M1l5cFdkbldpTERtbmszNHJrakl0NHhTRzc1OUY1MTN0c081MEZNamxrWk9QM0NjY2d2bzlNUFZMSUlCZkU2Qml2M1BXbmpSY1hPUUVLX21qUQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOOGJ6U084Y2J3VlBnNndQbV9BRkc5eHlOdzBPY09nVUt3TEkyTVozQ3NEV0JrN3dCNG4wUGNpc0hQNi1UMGZtcGN6QU1Nc0xQMEN0amZxUTNaemhzTEI5bkJJVU90ZElHZXQ0Q1F0bUI2M1l5cFdkbldpTERtbmszNHJrakl0NHhTRzc1OUY1MTN0c081MEZNamxrWk9QM0NjY2d2bzlNUFZMSUlCZkU2Qml2M1BXbmpSY1hPUUVLX21qUQ?oc=5", "title": "Entropy Neurodynamics Director Herwig Janssen Receives Shares in Lieu of Cash Fees", "content_text": "Entropy Neurodynamics Director Herwig Janssen Receives Shares in Lieu of Cash Fees", "date_published": "2026-08-07T04:30:27+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Balance sheet", "ENP"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ENP", "name": "Entropy Neurodynamics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/05ff8d4a-05f2-4a21-9c2f-f7d132822d6d/"}]}}, {"id": "source:60d8bf4285c1a876a5c71c05e34b26e820e68866e56c3e64a759321fc41b4003", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSVNYTUoxSW83MUlhYThXb09pYXBRNkVlOUI5RndQTDZQbGtTaXN1UGVtbUt0Tmx1QXJnUlU3akxaV2o4VE1JQU9NbTBKNnNvVXl3c3NKTS1xMlIxSm9yMjR4ZWpJdUhPR1BBMFc0QW5XVlpLMUNxLWxudlNzTzBjVm5YVmJDWlVCYnFELU5FbE55N2t1NlZudW96X3J2YUpCS1A0bGZKZjI0Mk03bDItU2t5aElsZVJt?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQSVNYTUoxSW83MUlhYThXb09pYXBRNkVlOUI5RndQTDZQbGtTaXN1UGVtbUt0Tmx1QXJnUlU3akxaV2o4VE1JQU9NbTBKNnNvVXl3c3NKTS1xMlIxSm9yMjR4ZWpJdUhPR1BBMFc0QW5XVlpLMUNxLWxudlNzTzBjVm5YVmJDWlVCYnFELU5FbE55N2t1NlZudW96X3J2YUpCS1A0bGZKZjI0Mk03bDItU2t5aElsZVJt?oc=5", "title": "Racura Oncology (ASX:RAC) in Focus as Investors Track Precision Medicine Progress", "content_text": "Racura Oncology (ASX:RAC) in Focus as Investors Track Precision Medicine Progress", "date_published": "2026-08-07T02:52:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "RAC"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "RAC", "name": "Racura Oncology Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/352ad92c-a187-4af9-b30c-507ada633040/"}]}}, {"id": "source:8f77b9dfc2f1c13bf5c653f955e6c58a0655d187eff39182f3c5ac275d735c92", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPcXBUMGp4Y3FQSnpGazZpR1NDeXEtcjJuSm1BWnkxcWo4SWFmTnFSc3hxLTNybXAya2hqU3hQS25DM09EeEpxUHVJOGFYUElzeEF2UlpFWnVWcHRBMzBvQlVGNUdSOGNwLXdVRHJLaGhkTzAxRWJHcFFjNV9HNjIxSkM1NFdBYm00cmE1aThlYzFucURqQjZDcGtKY3hCN1FCU3Z4RURVUlpQZU5FallzbHc2M3RzeFRicHI0?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPcXBUMGp4Y3FQSnpGazZpR1NDeXEtcjJuSm1BWnkxcWo4SWFmTnFSc3hxLTNybXAya2hqU3hQS25DM09EeEpxUHVJOGFYUElzeEF2UlpFWnVWcHRBMzBvQlVGNUdSOGNwLXdVRHJLaGhkTzAxRWJHcFFjNV9HNjIxSkM1NFdBYm00cmE1aThlYzFucURqQjZDcGtKY3hCN1FCU3Z4RURVUlpQZU5FallzbHc2M3RzeFRicHI0?oc=5", "title": "Entropy Neurodynamics Issues New Shares in Lieu of Directors\u2019 Fees", "content_text": "Entropy Neurodynamics Issues New Shares in Lieu of Directors\u2019 Fees", "date_published": "2026-08-07T00:55:35+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "ENP"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ENP", "name": "Entropy Neurodynamics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/05ff8d4a-05f2-4a21-9c2f-f7d132822d6d/"}]}}, {"id": "source:218be1be51d4c506de4f20aed9689530be6ba92338bd59027c166b00f7937979", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPbEJxYTR3WElYeUtWbTJtbndCVVNtVnhMZlV2UDM3eU9ZMGtnMnYwX3RyM3BBb2I3Q1pIcXZiSzRGQk5PSkM0M0dKdmFnekQ2NUEwUXpuWFBuTHZJVmx5SWFERTlWeTgyXzhtY0NyMTlpMGMtWVFWeUUzTGNBTW4yeXRyYlBCeDczVTNON0xQUE9ETTJqT0lpWTdpa0QtQ1J6TFA0d1BZZDlpZGZQZ2J5OWJNSXhneExYS0s0cGowTlJ6RHFH?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxPbEJxYTR3WElYeUtWbTJtbndCVVNtVnhMZlV2UDM3eU9ZMGtnMnYwX3RyM3BBb2I3Q1pIcXZiSzRGQk5PSkM0M0dKdmFnekQ2NUEwUXpuWFBuTHZJVmx5SWFERTlWeTgyXzhtY0NyMTlpMGMtWVFWeUUzTGNBTW4yeXRyYlBCeDczVTNON0xQUE9ETTJqT0lpWTdpa0QtQ1J6TFA0d1BZZDlpZGZQZ2J5OWJNSXhneExYS0s0cGowTlJ6RHFH?oc=5", "title": "Island Pharmaceuticals Targets Filovirus Threats With Galidesivir Strategy", "content_text": "Island Pharmaceuticals Targets Filovirus Threats With Galidesivir Strategy", "date_published": "2026-08-06T23:12:02+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "ILA"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ILA", "name": "Island Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/183d4f14-bb74-4dca-92e1-9b0dc5ce2015/"}]}}, {"id": "source:88aa56395af5af78c46625ddde965214a2ef35a6a492b18c7daec5f94400d3cc", "url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1lZTdQVWF6YjQ1MmFEdGp0THRfb3I4Nmo3U0EwQldZZThMeFMyVFQtRENWdU5HMHpueTdkenV2TnNtOWVxb1U1RlZ5MmpTN29hX2NvVXN2VW8?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiWEFVX3lxTE1lZTdQVWF6YjQ1MmFEdGp0THRfb3I4Nmo3U0EwQldZZThMeFMyVFQtRENWdU5HMHpueTdkenV2TnNtOWVxb1U1RlZ5MmpTN29hX2NvVXN2VW8?oc=5", "title": "ASX Penny Stocks Spotlight Clarity Pharmaceuticals And 2 More Compelling Picks", "content_text": "ASX Penny Stocks Spotlight Clarity Pharmaceuticals And 2 More Compelling Picks", "date_published": "2026-08-06T14:34:38+00:00", "authors": [{"name": "webull.com"}], "tags": ["Market update", "CU6"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CU6", "name": "Clarity Pharmaceuticals Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/5c03ba20-9b97-4e8a-9694-bfae1208f6d8/"}]}}, {"id": "source:5398b8f52bd4846b0c8b19fd30d1b4bdd3e52186b906cc82342c92ff3b2ca885", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOUE5IYzNCN1VnZGI2YzFDS3owVkVOQV9iTHVhZHh2TEwwZVlTUzZzTDRjd1pxa0FTN1I2WmVrQ0JRVEh0MUpVVHU0cU84T2JPUHFteFpUYTh5OXlTUjNGMk9raUQ3dkdTWlV5LWdLRUtDdEhEbU5JX3VnNkhkaWdiaVhST19qWk5jYmJBYUFPcWRSYm5tdm84YXZsaFFSVDR1cXAyck1sQkhURDJ3eWJjSk1pQ21lV2cyTWhiWE5lRVNyajA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOUE5IYzNCN1VnZGI2YzFDS3owVkVOQV9iTHVhZHh2TEwwZVlTUzZzTDRjd1pxa0FTN1I2WmVrQ0JRVEh0MUpVVHU0cU84T2JPUHFteFpUYTh5OXlTUjNGMk9raUQ3dkdTWlV5LWdLRUtDdEhEbU5JX3VnNkhkaWdiaVhST19qWk5jYmJBYUFPcWRSYm5tdm84YXZsaFFSVDR1cXAyck1sQkhURDJ3eWJjSk1pQ21lV2cyTWhiWE5lRVNyajA?oc=5", "title": "Botanix Pharmaceuticals (ASX:BOT) Gains as Sofdra Commercial Rollout Remains the Key Test", "content_text": "Botanix Pharmaceuticals (ASX:BOT) Gains as Sofdra Commercial Rollout Remains the Key Test", "date_published": "2026-08-06T10:35:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "BOT"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOT", "name": "Botanix Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/f2e15eba-2543-42d8-90a5-a50058dbac76/"}]}}, {"id": "source:741b324c20987bc9715b3c592285b0e6f189552376d3ff77270579789f974ecd", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPdWIxVmZtbkJmYUh4MTVIVVlSZW5tTkpfU2VTOWxRdDNjOHU2cGRDdVdfZUxmMmZwTDZJaF83eEZYOE1lQ3JfVmhoYm9JUHZlVzhGSXMwNV91NzNwODBmY2VRdEcyYUZiRzZxYW9PQnlCbUFZY1pDTjYxUVZzT1pfa0x3NTltUHBfXy1CT0g4dmx5d21xYVJRVmZsdWFESU1ibGlkNG5VeDlobTF1c1lQYUtrYXZ3ak81R2x3OU1vbEJGOUhFUTREWlBVOA?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPdWIxVmZtbkJmYUh4MTVIVVlSZW5tTkpfU2VTOWxRdDNjOHU2cGRDdVdfZUxmMmZwTDZJaF83eEZYOE1lQ3JfVmhoYm9JUHZlVzhGSXMwNV91NzNwODBmY2VRdEcyYUZiRzZxYW9PQnlCbUFZY1pDTjYxUVZzT1pfa0x3NTltUHBfXy1CT0g4dmx5d21xYVJRVmZsdWFESU1ibGlkNG5VeDlobTF1c1lQYUtrYXZ3ak81R2x3OU1vbEJGOUhFUTREWlBVOA?oc=5", "title": "Entropy Neurodynamics Issues Director Fee Shares, Confirms Regulatory Compliance", "content_text": "Entropy Neurodynamics Issues Director Fee Shares, Confirms Regulatory Compliance", "date_published": "2026-08-06T07:00:00+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Regulatory and legal", "ENP"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ENP", "name": "Entropy Neurodynamics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/05ff8d4a-05f2-4a21-9c2f-f7d132822d6d/"}]}}, {"id": "source:3b85578b73908aaa0623c33a623847b4041998e7e6ad4894638290eb039002d1", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Neuren Pharmaceuticals (ASX:NEU) Is Up 26.3% After Record DAYBUE Sales and Upgraded 2026 Royalties", "content_text": "Neuren Pharmaceuticals (ASX:NEU) Is Up 26.3% After Record DAYBUE Sales and Upgraded 2026 Royalties", "date_published": "2026-08-06T06:42:42+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Market update", "NEU"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "NEU", "name": "Neuren Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/1a99e02c-8452-4827-a2f2-f2d86b6c6b7f/"}]}}, {"id": "source:453a471c8d87a2be8f9e793b7705cd627981777233519f8d4f3f590aeff88605", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQM29aYUdxS05EbDVHT0Y5MUsweWxYOEZJWG9EcUhjOF9GTkhRNjJMT3JWaU1EcnFvbi1nc2xBZ3FIZEQ3a2x2NkdMYTRRWDF4dVAxQ3BaZ1I0SUEzV3gyY3lXTzNzNHo1X0NuQzZNZTNrSEpwRzdlM0VpbnktSEpWX201d3ViRnl2UmM5dDNHaWZPZ0J2MnY2clpCQlBsSTFqWVJucXl2dDg3aF9mcUYydGs1bEYwQkdWOG9rVllqbw?oc=5", "external_url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQM29aYUdxS05EbDVHT0Y5MUsweWxYOEZJWG9EcUhjOF9GTkhRNjJMT3JWaU1EcnFvbi1nc2xBZ3FIZEQ3a2x2NkdMYTRRWDF4dVAxQ3BaZ1I0SUEzV3gyY3lXTzNzNHo1X0NuQzZNZTNrSEpwRzdlM0VpbnktSEpWX201d3ViRnl2UmM5dDNHaWZPZ0J2MnY2clpCQlBsSTFqWVJucXl2dDg3aF9mcUYydGs1bEYwQkdWOG9rVllqbw?oc=5", "title": "Actinogen Medical Seeks ASX Quotation for 3.5 Million Incentive Shares", "content_text": "Actinogen Medical Seeks ASX Quotation for 3.5 Million Incentive Shares", "date_published": "2026-08-05T15:58:57+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "ACW"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ACW", "name": "Actinogen Medical Limited", "sentiment_url": "https://sharemaestro.com/sentiment/aabbf5e9-c8ed-46f9-8126-2ce2b36e90a5/"}]}}, {"id": "source:5b53e1dd14485a975b0ade0b85b31713ab60bb3eb21cd4ef686e687e55d33021", "url": "https://news.google.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?oc=5", "external_url": "https://news.google.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?oc=5", "title": "Paradigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook", "content_text": "Paradigm Biopharmaceuticals Limited's (ASX:PAR) Profit Outlook", "date_published": "2026-08-05T05:28:09+00:00", "authors": [{"name": "simplywall.st"}], "tags": ["Earnings", "PAR"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PAR", "name": "Paradigm Biopharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/d3eebfdd-3102-40c3-812c-c4fc1f64d7c4/"}]}}, {"id": "source:e71e4b9c87483ce4da521141d6feb3fad8ab174b52dcea76c68e44d44b6e3066", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNN08wNlZiSTVxcHFjWkJkR3dpV0UyWkFOUHFLeXoxRjZxTGV5QXBLVUkzQlllWHhTc1JBaTk3MWdFNEJPSUZJNG9ya0xJeVQ5elhQcDZKNDNuYzlwYzhGSTNnS29uNVJDMGpuSENEMWtuTHNEN1oxVnh2b05qSkpXUC16ZWRrTlU4alhwdk9TZXBLQ05OWkZGTkR2WUZmNUhLWHpKcDMyVVUzQ2MyZUZBUHlGM05pS0JPYzAtTWVUOVE?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxNN08wNlZiSTVxcHFjWkJkR3dpV0UyWkFOUHFLeXoxRjZxTGV5QXBLVUkzQlllWHhTc1JBaTk3MWdFNEJPSUZJNG9ya0xJeVQ5elhQcDZKNDNuYzlwYzhGSTNnS29uNVJDMGpuSENEMWtuTHNEN1oxVnh2b05qSkpXUC16ZWRrTlU4alhwdk9TZXBLQ05OWkZGTkR2WUZmNUhLWHpKcDMyVVUzQ2MyZUZBUHlGM05pS0JPYzAtTWVUOVE?oc=5", "title": "How Does Why Watch Botanix Pharmaceuticals (ASX:BOT) Fit the 5 August Market Shift?", "content_text": "How Does Why Watch Botanix Pharmaceuticals (ASX:BOT) Fit the 5 August Market Shift?", "date_published": "2026-08-05T04:03:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "BOT"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOT", "name": "Botanix Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/f2e15eba-2543-42d8-90a5-a50058dbac76/"}]}}, {"id": "source:7fe579665847d2c1ad2df0c53ecf5e59b6bab8f2356bb2e812c1d4503ce3b32f", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPWUN6OE90VDBwTzNFQVlJenJ0YmVIZjJmYzQ2M214dUhsU3lqSUpXRFN2ZmpaaFRoY2oyMzlDSUdHWHlDR0xhTnZ4QVVrN1ltdjBxRWd6bjdzTnlpcEUtdFRYWlVBY0VYQUZuNDc1MnZOcGVTcmVFMzhsUzlxVEdHcnVzVkRPc2toZTdzb3hJdVJuRGNpekc0cUxJdzF4dE9CWkRKU1VldmIyTHhyM0Z5ZnRUZUZNcEk?oc=5", "external_url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPWUN6OE90VDBwTzNFQVlJenJ0YmVIZjJmYzQ2M214dUhsU3lqSUpXRFN2ZmpaaFRoY2oyMzlDSUdHWHlDR0xhTnZ4QVVrN1ltdjBxRWd6bjdzTnlpcEUtdFRYWlVBY0VYQUZuNDc1MnZOcGVTcmVFMzhsUzlxVEdHcnVzVkRPc2toZTdzb3hJdVJuRGNpekc0cUxJdzF4dE9CWkRKU1VldmIyTHhyM0Z5ZnRUZUZNcEk?oc=5", "title": "Amplia Therapeutics (ASX:ATX) Gains as Narmafotinib Adds an Ovarian Cancer Study", "content_text": "Amplia Therapeutics (ASX:ATX) Gains as Narmafotinib Adds an Ovarian Cancer Study", "date_published": "2026-08-04T09:17:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATX", "name": "Amplia Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/092cfe2d-9146-46c4-8b42-f095a50ab572/"}]}}, {"id": "source:35a415ea3faab228fae02e251236a0d3cf057148512dfad2711fbb958f6c5748", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPTkFkSVV0WVcybHV2NEZjWG1fR3ZTcUFoa2NsQ3ZDd3ZQWERNem1YaUR5RUFRR2tZU3FfU3JVOEtHb25QWE9vUGpRWXF3T3U1YTJpdVFBUEJCcmUtSjd2LUJ2eFhDT0lWOHE5dXlKc1c0WHFtOHRZektwUmdoZExJWk02RHA2X2JPRTJzT1M5SERDZ2ZsaFJvcUs2R04wUWlLdjFwamFaNE9vWUszS3k4Z29kZGZKT25wQ3QwVnV6Nmw3VUNIcENJdnhRTQ?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxPTkFkSVV0WVcybHV2NEZjWG1fR3ZTcUFoa2NsQ3ZDd3ZQWERNem1YaUR5RUFRR2tZU3FfU3JVOEtHb25QWE9vUGpRWXF3T3U1YTJpdVFBUEJCcmUtSjd2LUJ2eFhDT0lWOHE5dXlKc1c0WHFtOHRZektwUmdoZExJWk02RHA2X2JPRTJzT1M5SERDZ2ZsaFJvcUs2R04wUWlLdjFwamFaNE9vWUszS3k4Z29kZGZKT25wQ3QwVnV6Nmw3VUNIcENJdnhRTQ?oc=5", "title": "Recce Pharmaceuticals Issues 250,000 New Shares Under Corporations Act Exemption", "content_text": "Recce Pharmaceuticals Issues 250,000 New Shares Under Corporations Act Exemption", "date_published": "2026-08-04T07:19:37+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "RCE"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "RCE", "name": "Recce Pharmaceuticals Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/31c24033-052d-410b-86ba-a577747db270/"}]}}, {"id": "source:4234875cc4e43dc5575ae53a9236f0a4c1085531cec290682e605d152ba71d08", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNejdicVJ2aGI2WEhJdTFVeVBORllpVVRRZEE3VFlCajBPLWI2T0xLR2pyLVRXbF9oOU9mU0lDTGU2LTlrYnZEeG0yOUI5YXpSVjJrS0ZIRUNlUEFXRjNGV1ZYbnFjR1o2OXlNQjV5Q1Z3TFlFc2k5QTJWWmV5M3FXYUptZjF0T1ByOFpueWtPWkxYTjBydDdLM29fZmFvVmNYd0dMU0I0NUMwa1JaRHU4elhKZklaZ3VvTDhJeHZyaGJVTE8xeDZkSmFDVnp6N2lV?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNejdicVJ2aGI2WEhJdTFVeVBORllpVVRRZEE3VFlCajBPLWI2T0xLR2pyLVRXbF9oOU9mU0lDTGU2LTlrYnZEeG0yOUI5YXpSVjJrS0ZIRUNlUEFXRjNGV1ZYbnFjR1o2OXlNQjV5Q1Z3TFlFc2k5QTJWWmV5M3FXYUptZjF0T1ByOFpueWtPWkxYTjBydDdLM29fZmFvVmNYd0dMU0I0NUMwa1JaRHU4elhKZklaZ3VvTDhJeHZyaGJVTE8xeDZkSmFDVnp6N2lV?oc=5", "title": "Recce Pharmaceuticals Files Cleansing Notice After Issuing 250,000 Shares on July 31, 2026", "content_text": "Recce Pharmaceuticals Files Cleansing Notice After Issuing 250,000 Shares on July 31, 2026", "date_published": "2026-08-04T07:04:52+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "RCE"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "RCE", "name": "Recce Pharmaceuticals Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/31c24033-052d-410b-86ba-a577747db270/"}]}}, {"id": "source:e44667e1a1043f44a077c932b119f9f09ff9d828a4e5f71bb5a5b9d3ca002d4c", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNNHduZ2xFMnZ1WmtBUmMxd3V4VEVoLURhSF9kckt2Z3hfTjg2T0hXVmtYMXMxSU1KWDNCRHk3UDBCejZnWU4tZXJVUmRpa045UW10S0EzUjJFZ0Fydl9jcUp6dm5nako2RnM4bC02TmpaRC1TVHYwb2FEMWtHQmZsWVgtX1o3amVEc0FtTUQzdFN3VndwVVcxZlM4Y3hLS1J2QkRhRDcwb0hKOFhhVUJSUllUSmRJYmJmWFczRV9GN3M3S0U?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNNHduZ2xFMnZ1WmtBUmMxd3V4VEVoLURhSF9kckt2Z3hfTjg2T0hXVmtYMXMxSU1KWDNCRHk3UDBCejZnWU4tZXJVUmRpa045UW10S0EzUjJFZ0Fydl9jcUp6dm5nako2RnM4bC02TmpaRC1TVHYwb2FEMWtHQmZsWVgtX1o3amVEc0FtTUQzdFN3VndwVVcxZlM4Y3hLS1J2QkRhRDcwb0hKOFhhVUJSUllUSmRJYmJmWFczRV9GN3M3S0U?oc=5", "title": "Paradigm Biopharmaceuticals (ASX:PAR) Gains as Phase 3 Safety Review Clears the Next Gate", "content_text": "Paradigm Biopharmaceuticals (ASX:PAR) Gains as Phase 3 Safety Review Clears the Next Gate", "date_published": "2026-08-04T07:00:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "PAR"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "PAR", "name": "Paradigm Biopharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/d3eebfdd-3102-40c3-812c-c4fc1f64d7c4/"}]}}, {"id": "source:6cd2520a96b5654d49ee6604aae5fe4ba49b0415974b2d6f513cebe58cc54ce8", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOM1lYZHhFc1ZBYmQ4NzY4RERXbnpWendfV09pY3hmMEpuZjRnYlphZmNwdXJaSU5ISGxQMTlEd3JuQm5fSE5Mdm10Zm1EMGh6SmEyZnktQ2FrWC1teHRLaUctSU15aUx6YUlPNUlkd2VSMm10ZU5xbXFWc1pOMTQ2MDVtbVZNR3Rja1FjUlIwNnNobkVMWFQxWjFma0xNc0VVZkdXM1VTWUg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxOM1lYZHhFc1ZBYmQ4NzY4RERXbnpWendfV09pY3hmMEpuZjRnYlphZmNwdXJaSU5ISGxQMTlEd3JuQm5fSE5Mdm10Zm1EMGh6SmEyZnktQ2FrWC1teHRLaUctSU15aUx6YUlPNUlkd2VSMm10ZU5xbXFWc1pOMTQ2MDVtbVZNR3Rja1FjUlIwNnNobkVMWFQxWjFma0xNc0VVZkdXM1VTWUg?oc=5", "title": "Amplia Therapeutics (ASX: ATX) Announces Lilly Clinical Collaboration", "content_text": "Amplia Therapeutics (ASX: ATX) Announces Lilly Clinical Collaboration", "date_published": "2026-08-04T00:43:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "ATX"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "ATX", "name": "Amplia Therapeutics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/092cfe2d-9146-46c4-8b42-f095a50ab572/"}]}}, {"id": "source:b21d52d8b92f8b539e38ab041d6b76828031b313d939291ab1a4679fe401b40f", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQVW84YXJkcGVXQUZ5OVdaMVFVVzlkS2FUVlVOYjc3cFhXN1hoUWZ3ZWVUX08yb2l4cWxpMU04bDJQTjdRT0lXZ2lCUTVnQkxMcU9WeW9UR3J1eHlsYl9QQm9BOHNPNEJFQlV3NnRBa0djbWdFbDZHbHBnZEdFcDhVTDVTWVhJTlAwa3JidGNGVjVwR1IzR0xneU9fZDF3dzU4SmdJcVdlVjJaZUczallrMFd0ZlJ0OWUwdnlVTDZib0c4WnJC?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxQVW84YXJkcGVXQUZ5OVdaMVFVVzlkS2FUVlVOYjc3cFhXN1hoUWZ3ZWVUX08yb2l4cWxpMU04bDJQTjdRT0lXZ2lCUTVnQkxMcU9WeW9UR3J1eHlsYl9QQm9BOHNPNEJFQlV3NnRBa0djbWdFbDZHbHBnZEdFcDhVTDVTWVhJTlAwa3JidGNGVjVwR1IzR0xneU9fZDF3dzU4SmdJcVdlVjJaZUczallrMFd0ZlJ0OWUwdnlVTDZib0c4WnJC?oc=5", "title": "Could Clarity Pharmaceuticals (ASX:CU6) Be Australia's Next Small-Cap Healthcare Surprise?", "content_text": "Could Clarity Pharmaceuticals (ASX:CU6) Be Australia's Next Small-Cap Healthcare Surprise?", "date_published": "2026-08-04T00:12:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "CU6"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "CU6", "name": "Clarity Pharmaceuticals Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/5c03ba20-9b97-4e8a-9694-bfae1208f6d8/"}]}}, {"id": "source:970d1c1fa8b87c1f127fb2fa702704acdbd758a2e6d1788eee4a140600dd9c91", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdTN2dHB4Rm5rN3VfLXZpY3J5NGdDRnRPdjZCenZ4amNnUzhJakVpbUhXOVRmSFpZLV82a2hfNmI2SDlqT3VZVHJPYmplVkFPR2RGQ2hZOWJ6bkZWNmxVSTlYeUN0WndoMUgzNEk2WXR2c080YnVrUXJFeGtKUkxmUFR0RGJDenZhei00UjU1Y2VPVlppNWFzMjZhSG80YVJlcDBHUVpVdHdVLS1PUGl0d1lQTkFES2locEVzdEJzRWJfZm9hZFU1a0lHYmRQOE5kem5Meg?oc=5", "external_url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxNdTN2dHB4Rm5rN3VfLXZpY3J5NGdDRnRPdjZCenZ4amNnUzhJakVpbUhXOVRmSFpZLV82a2hfNmI2SDlqT3VZVHJPYmplVkFPR2RGQ2hZOWJ6bkZWNmxVSTlYeUN0WndoMUgzNEk2WXR2c080YnVrUXJFeGtKUkxmUFR0RGJDenZhei00UjU1Y2VPVlppNWFzMjZhSG80YVJlcDBHUVpVdHdVLS1PUGl0d1lQTkFES2locEVzdEJzRWJfZm9hZFU1a0lHYmRQOE5kem5Meg?oc=5", "title": "Radiopharm Theranostics Applies to Quote 408.8 Million Shares from Tranche 1 Australian Placement", "content_text": "Radiopharm Theranostics Applies to Quote 408.8 Million Shares from Tranche 1 Australian Placement", "date_published": "2026-08-03T07:00:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "RAD"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "RAD", "name": "Radiopharm Theranostics Limited", "sentiment_url": "https://sharemaestro.com/sentiment/4df94284-1220-420e-a52a-fb738f3845e7/"}]}}, {"id": "source:1184fa44b37f52124592310bad43ed6e6f9115fe3654aaedfaa48e7a2b153cdc", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNMG5TSUMtdzRXQjF1aDNwSEowQVhjUkViQ01fWnJCWVg0LWVSdExyVWlQRlNQbEhhbTRyYmIzdXNRZTJWbHlMNTl0WExYRzFLVzdGTkZsaUgza3d1X3l5OXI4VWRGYXFoaThOVDlKMFN4RTctT2pheFVqRzdCVTlLd2FfTm1VUWJodmtOUFNoalV4V05Dcmhxd3d6QXVjZGNtakROZFF3WDZZQmpRLThsS1NFaGhHTlVvVGU5OGN1d2c3SGc?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxNMG5TSUMtdzRXQjF1aDNwSEowQVhjUkViQ01fWnJCWVg0LWVSdExyVWlQRlNQbEhhbTRyYmIzdXNRZTJWbHlMNTl0WExYRzFLVzdGTkZsaUgza3d1X3l5OXI4VWRGYXFoaThOVDlKMFN4RTctT2pheFVqRzdCVTlLd2FfTm1VUWJodmtOUFNoalV4V05Dcmhxd3d6QXVjZGNtakROZFF3WDZZQmpRLThsS1NFaGhHTlVvVGU5OGN1d2c3SGc?oc=5", "title": "Botanix Pharmaceuticals (ASX:BOT) \u2013 Jumps 5 Per Cent on a Single Tick, Not a Biotech Revival", "content_text": "Botanix Pharmaceuticals (ASX:BOT) \u2013 Jumps 5 Per Cent on a Single Tick, Not a Biotech Revival", "date_published": "2026-08-03T07:00:00+00:00", "authors": [{"name": "Kalkine"}], "tags": ["Market update", "BOT"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "BOT", "name": "Botanix Pharmaceuticals Limited", "sentiment_url": "https://sharemaestro.com/sentiment/f2e15eba-2543-42d8-90a5-a50058dbac76/"}]}}, {"id": "source:21923a790d0bb18b64cde186c5e9ac86c93eefaa3f26bdc713062405d15dce5c", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPa1NtX2tMOVgzUkxVb1pybVdUTjI2V0UtR0czeHdqdGhtMnRfUWRoNG9nT0YzQlFLOWV4Vkc2ZTFBMnoyZDBULW9hb3I5YUZISDVRTUtPckNCSE1LT0dhNmRhTTR3VUFubkl0dGVyVm1WN2FEOWgyU1RlSUVoeGs5bXVUbGdJR0taTjI0SDFGdlo4UG1kbF9KakplQWdqdmU1eVk0LS1NUHY0LXpOQnFLNHRMdU5pMkRGdVAwd0Y3RWM2M0s4eFQ4?oc=5", "external_url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPa1NtX2tMOVgzUkxVb1pybVdUTjI2V0UtR0czeHdqdGhtMnRfUWRoNG9nT0YzQlFLOWV4Vkc2ZTFBMnoyZDBULW9hb3I5YUZISDVRTUtPckNCSE1LT0dhNmRhTTR3VUFubkl0dGVyVm1WN2FEOWgyU1RlSUVoeGs5bXVUbGdJR0taTjI0SDFGdlo4UG1kbF9KakplQWdqdmU1eVk0LS1NUHY0LXpOQnFLNHRMdU5pMkRGdVAwd0Y3RWM2M0s4eFQ4?oc=5", "title": "Why Is Recce Pharmaceuticals (ASX:RCE) In Focus After Seeking Quotation Of New Shares?", "content_text": "Why Is Recce Pharmaceuticals (ASX:RCE) In Focus After Seeking Quotation Of New Shares?", "date_published": "2026-08-03T07:00:00+00:00", "authors": [{"name": "Kalkine Media"}], "tags": ["Market update", "RCE"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "RCE", "name": "Recce Pharmaceuticals Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/31c24033-052d-410b-86ba-a577747db270/"}]}}, {"id": "source:77c0876f0aba55f049064cbba95befc209665680dbbc066391c1a0c2c1d2108e", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQjI3VmJJdHNBU1lHaFVFLTI2YnN6RDhtNk90NFdvYU95dkktR0k3ci1RUHNiTEx2ZTk4WFBUVDdra2lpX0ZGWmRNZzR4R1pWYTVfaW5uYl9SeVdleVNZd3BPT1ZZTHE0WVBTanlmZTZBRDZKQ3luSWhlT28xNTBWSjBNcVlXNnYxaU1FWVBNUnRtRjF2S2R5bGtZWGtTUF9zS0ZrY1loUUpOanNkS1Vod25INUdTRUJK?oc=5", "external_url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQQjI3VmJJdHNBU1lHaFVFLTI2YnN6RDhtNk90NFdvYU95dkktR0k3ci1RUHNiTEx2ZTk4WFBUVDdra2lpX0ZGWmRNZzR4R1pWYTVfaW5uYl9SeVdleVNZd3BPT1ZZTHE0WVBTanlmZTZBRDZKQ3luSWhlT28xNTBWSjBNcVlXNnYxaU1FWVBNUnRtRjF2S2R5bGtZWGtTUF9zS0ZrY1loUUpOanNkS1Vod25INUdTRUJK?oc=5", "title": "Recce Pharmaceuticals Seeks ASX Quotation for Advisory Fee Shares", "content_text": "Recce Pharmaceuticals Seeks ASX Quotation for Advisory Fee Shares", "date_published": "2026-08-02T22:58:28+00:00", "authors": [{"name": "TipRanks"}], "tags": ["Market update", "RCE"], "_sharemaestro": {"country": "Australia", "coverage": "Main company", "market_context": null, "companies": [{"symbol": "RCE", "name": "Recce Pharmaceuticals Ltd", "sentiment_url": "https://sharemaestro.com/sentiment/31c24033-052d-410b-86ba-a577747db270/"}]}}]}